The Food and Drug Administration has published new information for businesses seeking guidance on how to label foods that ...

Learn more. The March 16 Maine Sunday Telegram reported that the USDA canceled contracts to continue providing food and funding to Maine schools and nonprofits for three more years. Really?

A fish allergy, as opposed to a shellfish allergy, is one in which your immune system reacts abnormally to a finned fish such as tuna, halibut, or salmon. It is a somewhat less common form of food ...

These changes will provide essential information to help people with a food allergy or intolerance make safe food choices. If you provide non-prepacked foods, you must supply allergen information for ...

13. Around 6% of the UK adult population have a food allergy; this figure does not include those with food intolerances. In addition, it is estimated that 1 in 100 people have coeliac disease, a ...

I write in response to Ron Martin’s letter published March 3, 2025, regarding gates on snowplows. He mentioned some cities that have these attachments. I remember Fargo investigating this item a ...

Pollen from some trees will reach its peak in early May. As winter winds down and spring approaches, allergy season is also around the corner. Unfortunately for those in New Jersey who suffer ...

This experience only added to Auerbach’s commitment to food allergy education, a cause she has long been passionate about. Auerbach and Weinberg senior Kethan Bajaj are co-presidents of College ...

A landmark clinical trial has discovered that omalizumab, marketed as Xolair, provides more effective treatment for multiple food allergies than the current standard approach of oral immunotherapy ...

If you have an allergy that doesn't get better easily with over-the-counter medications, or if you think you might have a food allergy, see a doctor who specializes in allergies called an allergist.

Jim Jones, director of the Food and Drug Administration’s food ... Kennedy Jr. in his resignation letter to acting FDA commissioner Sara Brenner, which The Washington Post has reproduced below.

A clinical trial found that omalizumab (Xolair) was more effective than oral immunotherapy (OIT) in treating multi-food allergies, particularly in individuals who react to very small amounts of common ...